Stock Analiz

OneMedNet Corp ONMD

Biotechnology: Commercial Physical & Biological Resarch · IPO 2021 · data as of November 13, 2026

$5.34Market cap $32M
Open the interactive analysis →

OneMedNet Corp (ONMD) is a healthcare company listed in the US with a market value of about $32M. In the twelve months to June 30, 2026 it had revenue of $1M and net income of -$9M, a net margin of -584.2%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

About OneMedNet

OneMedNet is listed in the US and classified in biotechnology: commercial physical & biological resarch, IPO year 2021. Revenue went from $1M in 2022 to $1M in 2025, growth of about 5.6% a year. It was profitable in 0 of the last 4 years in our data. Its share count rose by 1021% over three years (dilution for shareholders). It spends 111% of revenue on research and development.

Score: 1.0 / 5

Value0/5
Future growth3/5
Track record1/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • ROE above 15%
  • More cash than debt, or low debt to equity

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S22.1
P/B—
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-21.5%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)111.3%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-1932.7%
ROIC (5-yr avg.)—
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 4 years

Fiscal yearTTM2025202420232022
Revenue$1M$1M$643000$1M$1M
Net income-$9M-$3M-$10M-$34M-$30M
Free cash flow-$7M-$8M-$7M-$5M-$5M
EPS (diluted)$-0.16$-0.06$-0.36$-4.65$-7.66
Net margin-584.2%-206.1%-1575.3%-3308.5%-2641.0%
ROIC—————

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does OneMedNet pay a dividend?

Not currently.

Is OneMedNet a good stock to buy?

We do not give buy or sell advice. OneMedNet scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.